AiB-001

N/A

Report date: 2025/03/14 16:54:30
NME

Base Information

Drug NameAiB-001
Drug Alias NameHBV polymerase inhibitor (Ai-biopharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAi-biopharma SAS
China Registration ClassN/A

Develop Information

Active CompaniesAi-biopharma SAS
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A